Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Total Current Liabilities (2020 - 2025)

BioAtla's Total Current Liabilities history spans 6 years, with the latest figure at $21.9 million for Q4 2025.

  • For Q4 2025, Total Current Liabilities rose 50.77% year-over-year to $21.9 million; the TTM value through Dec 2025 reached $21.9 million, up 50.77%, while the annual FY2025 figure was $21.9 million, 50.77% up from the prior year.
  • Total Current Liabilities reached $21.9 million in Q4 2025 per BCAB's latest filing, up from $18.0 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $45.2 million in Q3 2021 to a low of $14.5 million in Q4 2024.
  • Average Total Current Liabilities over 5 years is $24.4 million, with a median of $22.5 million recorded in 2022.
  • Peak YoY movement for Total Current Liabilities: skyrocketed 52.78% in 2023, then plummeted 48.7% in 2024.
  • A 5-year view of Total Current Liabilities shows it stood at $19.8 million in 2021, then increased by 16.75% to $23.1 million in 2022, then grew by 22.54% to $28.3 million in 2023, then tumbled by 48.7% to $14.5 million in 2024, then surged by 50.77% to $21.9 million in 2025.
  • Per Business Quant, the three most recent readings for BCAB's Total Current Liabilities are $21.9 million (Q4 2025), $18.0 million (Q3 2025), and $16.6 million (Q2 2025).